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Objectives: Many older adults with depression do not receive adequate treatment. 
Differences in treatment utilization may reflect the heterogeneous nature of depression, 
encompassing multiple distinct symptoms. We assessed whether depressive symptoms are 
differentially associated with subsequent health care utilization with respect to three 
outcomes: 1) contact with a medical doctor (MD), 2) depression-specific treatment and 3) 
inpatient psychiatric admission.  
Methods/Design: Longitudinal analyses were based on data from three follow-up cycles 
conducted between 2004 and 2013 among 53,139 participants from the Survey of Health, 
Aging and Retirement in Europe. Depressive symptoms were self-reported at baseline of 
each follow-up cycle using the 12-item EURO-D scale. Health care utilization was self-
reported at the end of each follow-up cycle.  
Results: After adjustment for sex, age, country of interview, follow-up time, educational 
attainment, presence of a partner in household, body-mass index, the number of chronic 
diseases, disability and average/prior frequency of contact with an MD, people with more 
frequent contact with an MD had most often reported sleep problems (IRR=1.10) and fatigue 
(IRR=1.10), followed by sad/depressed mood, tearfulness, concentration problems, guilt, 
irritability and changes in appetite. Those treated for depression had most often reported 
sad/depressed mood (OR=2.18) and suicidal ideation (OR=1.72), but also sleep problems, 
changes in appetite, fatigue, concentration problems, hopelessness and irritability. 
Sad/depressed mood (OR=2.87) was also associated with psychiatric inpatient admission. 
Similarly to other outcomes, appetite change, fatigue and sleep problems were associated 
with inpatient admission.   
Conclusions: Specific symptoms of depression may determine utilization of different types 
of health care among elderly.  
 





- We examined whether specific depressive symptoms are differentially related to 
health care utilization. 
- Those with frequent contact with a medical doctor most often reported prior 
fatigue and sleep problems, whereas those receiving depression-specific treatment 
most typically reported prior sad/depressed mood and suicidal ideation. 
Sad/depressed mood was the most important predictor of psychiatric inpatient 
admission. 
- Symptom-level differences in treatment-seeking behavior may be helpful in 
understanding mental health care associated with depression among elderly 







Depressive symptoms tend to increase when people transition from middle adulthood to older 
age, often together with worsening physical health.1–3 Depressive symptoms among the 
elderly are frequently comorbid with chronic diseases, disability and dementia, which may 
complicate differential diagnosis and treatment options.3,4 Despite the adverse psychosocial 
effects of even mild depressive symptoms in older adults,1,2 most people suffering from 
depressive symptoms do not receive adequate treatment.2,3,5  
 
Several factors can contribute to why some individuals are more or less likely to be treated.6,7 
This may partly reflect the heterogeneous nature of depression. Depression is characterized 
by a number of distinct symptoms which can form unique combinations within individuals, 
and people with depression may thus have different symptom profiles. Previous studies have 
shown the different symptoms of depression to be differently related to biological and social 
risk factors and functional impairment.8 Thus, the symptoms of depression might also be 
differently related to people’s probability of seeking treatment. 
 
The few previous studies comparing associations of different depressive symptoms and 
health care utilization have reported mixed findings.9–13 Furthermore, these studies have been 
based on cross-sectional samples of clinically depressed individuals in young or middle 
adulthood. The longitudinal associations of depressive symptoms with health care utilization 
among older adults in the general population are not known. We used data from the 
longitudinal population-based multi-country Survey of Health, Aging and Retirement in 
Europe (SHARE) to examine whether some depressive symptoms are particularly relevant in 
predicting subsequent health care utilization among older adults. We assessed treatment 
contact in general (contact with a medical doctor (MD)) and psychiatric treatment contact 
specifically (treatment for depression and inpatient psychiatric admission). Because somatic 
depressive symptoms – fatigue, sleep problems, appetite change and psychomotor retardation 
or agitation – have been linked to poor physical health,14,15 we hypothesized that somatic 
symptoms would be associated with treatment contact in general. Moreover, we anticipated 
that cognitive/affective depressive symptoms – diminished interest, sad mood, hopelessness, 
suicidal ideation and concentration difficulties – would be particularly relevant in 




MATERIALS AND METHODS 
Sample 
The Survey of Health, Aging and Retirement in Europe (SHARE) is a cross-national panel 
study that has collected data from up to 140,000 persons from 27 European countries and 
Israel. To date, SHARE comprises 7 study waves. The SHARE target population consists of 
all persons aged 50 years and older at the time of sampling who have their regular domicile in 
the respective SHARE country (persons are excluded if they are incarcerated, hospitalized, or 
out of the country during the entire survey period, unable to speak the country’s languages). 
The sampling is designed to draw inferences about the population of people aged 50 years 
and older across countries by using probability-based sampling. In Wave 1, all age-eligible 
persons per sampled household (plus their partners, regardless of age) were selected for an 
interview. Since Wave 2, only one age-eligible person per household (plus partner, regardless 
of age) has been selected. All SHARE respondents who were interviewed in any previous 
wave (including non-responding partners) are part of the longitudinal sample. Additionally, 
refreshment samples are drawn regularly to maintain representation of the younger age-
cohorts of the target population that were not age-eligible in previous waves, and to 
compensate for the reduction in panel sample size due to attrition.16 More details about the 
sample can be found at http://www.share-project.org/.    
In this study, we used all available data on depressive symptoms and health care utilization 
with respect to three outcomes: 1) any contact with an MD, 2) treatment for depression and 3) 
inpatient psychiatric admission. These data comprised three follow-ups: from Wave 1 (taking 
place in 2004-2006) to 2 (2006-2010), 2 to 4 (2010-2012) and 4 to 5 (2013) (Table 1).17–24 A 
total of 55,750 individuals were initially eligible for this study, as they had data on depressive 
symptoms and covariate data in at least one follow-up. Different subsamples of these initially 
eligible participants were used in the analyses for the three outcomes. First, in analyses on the 
association between depressive symptoms and contact with an MD, 2,846 participants 
initially eligible were excluded due to missing outcome data in all follow-ups, which left a 
study population of 52,904. Second, in analyses on the association between depressive 
symptoms and treatment for depression, 29,813 participants initially eligible were excluded 
due to missing outcome data in all follow-ups (n=27,066) or prior depression 
treatment/inpatient psychiatric admission (n=2,747), which left a study population of 25,937. 
Third, in analyses on the association between depressive symptoms and inpatient psychiatric 
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admission, 27,496 participants initially eligible were excluded due to missing outcome data 
in all follow-ups (n=27,067) or prior psychiatric admission (n=429), which left a study 
population of 28,254. Across the three outcomes, a total of 53,139 participants contributed 
79,467 person-observations in the analyses during the follow-up. The number of included 
individuals with exposure and outcome data in each follow-up is presented in Table 1.   
The authors assert that all procedures contributing to this work comply with the ethical 
standards of the relevant national and institutional committees on human experimentation and 
with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human 
subjects/patients were approved by the Ethics Committee of the University of Mannheim 
(Waves 1 to 4) and by the Ethics Council of the Max Planck Society (Wave 5). Depending on 
the country of interview, written or verbal consent was obtained from all participants. Verbal 
consent was witnessed and formally recorded.  
 
[ Table 1 ] 
 
Health care utilization 
Health care utilization was assessed with three separate outcomes: 1) frequency of contact 
(i.e., number of visits) with an MD during the past 12 months, 2) treatment for depression by 
a doctor or psychiatrist (ever/never) and 3) inpatient psychiatric admission (ever/never).  
 
Data on the frequency of contact with an MD was self-reported by participants as the number 
of times they visited or had contact with an MD during the past 12 months (top-coded to 30 
visits), without asking the specific reasons for the MD visits. Data on the frequency of 
contact with an MD was recorded in all three follow-ups (Table 1). Data on both treatment 
for depression (ever/never treated for depression by a doctor or psychiatrist) and on inpatient 
psychiatric admission (ever/never admitted to a psychiatric hospital or psychiatric ward) were 
self-reported by participants, and recorded in the two first follow-ups (Table 1). 
 
Depressive symptoms 
Depressive symptoms were self-reported using the 12-item EURO-D scale.25,26 EURO-D has 
been developed to allow comparisons of depression symptom profiles between European 
countries and has previously been validated in the cross-European EURODEP study.25,26 
EURO-D includes dichotomous items (yes/no) measuring sad/depressed mood, hopelessness, 
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suicidal ideation, guilt, sleep problems, diminished interest, irritability, changes in appetite, 
fatigue, concentration problems, lack of enjoyment and tearfulness during the past month. 
Depressive symptoms were assessed in all three follow-ups (Table 1).  
 
Confounders 
All analyses were adjusted for sex, age, country of interview, follow-up time, and all 
depressive symptoms in each follow-up. We additionally adjusted the analyses for 
educational attainment, presence of a partner in household, body mass index (BMI), the 
number of chronic diseases, disability and frequency of contact with an MD at the follow-up 
baseline. Sex and age were self-reported. Country of interview was recorded as part of the 
data collection. Educational attainment was measured through self-reports according to the 
International Standard Classification of Education (ISCED-97) on a 7-point scale: pre-
primary, primary, lower secondary, (upper) secondary, post-secondary non tertiary, first stage 
of tertiary (not leading directly to an advanced research qualification) and second stage of 
tertiary education (leading to an advanced research qualification). The presence of a partner 
in household (yes/no) was self-reported. BMI (kg/m2) was assessed using self-reported height 
and weight, and the number of chronic diseases was measured as a count of self-reported 
diagnoses (yes/no) of diabetes, high blood pressure, stroke, heart attack, chronic lung disease 
and cancer. Disability (yes/no) was assessed through self-reported limitations using the 
Activities of Daily Living scale of 10 items (0 limitations vs ≥1 limitation). 
  
Statistical analysis 
Associations of depressive symptoms with frequency of contact with an MD were estimated 
with multilevel, random-intercept negative binomial regression models. The negative 
binomial regression was used to model the count outcome with overdispersion and the 
random-intercept multilevel model took into account the non-independence of the repeated 
person-observations from the same individuals and the average rates of MD visits between 
individuals. Associations of depressive symptoms with treatment for depression and inpatient 
psychiatric admission were assessed with multilevel, random-intercept logistic regression 
models. All analyses were conducted using time-lagged time intervals in the exposure and 
outcome measurement within each follow-up, so that treatment outcomes measured at the end 
of each follow-up were regressed on depressive symptoms (and confounders) measured at the 
follow-up baseline (Table 1). All three health care utilization outcomes (contact with an MD, 
treatment for depression and inpatient psychiatric admission) were analyzed in separate 
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models. We first assessed the associations in minimally adjusted models controlling for sex, 
age, country of interview, follow-up time and all other depressive symptoms. Then we further 
adjusted these models for educational attainment, presence of a partner in household, BMI, 
the number of chronic diseases and disability. When assessing treatment for depression and 
inpatient psychiatric admission, these fully adjusted models were also adjusted for the 
frequency of contact with an MD at the follow-up baseline. In analyses on the frequency of 
contact with an MD, the average differences in the outcome were already modelled by the 
random intercept of the multilevel model. Selective attrition was assessed with random-
intercept multilevel logistic regression predicting attrition at the end of each follow-up by the 
EURO-D sum score and individual depressive symptoms at the follow-up baseline. The 
results of the attrition analyses are presented in Supplementary Tables 1–2. All analyses 
were conducted in Stata 16.0 (StataCorp, College Station, TX, USA). 
 
RESULTS 
Supplementary Table 3 presents the characteristics of 53,139 SHARE participants. Across 
all follow-ups, there were 30,227 (57%) women. The mean age was 64.5 (SD, 10.0). Mean 
frequency of contact with an MD (during past 12 months within each follow-up) was 6.5 
(SD, 6.8). A total of 2,433 (5%) participants received treatment for depression and 286 (<1%) 
were admitted to inpatient psychiatric treatment. Correlations between depressive symptoms 
were from weak to moderate (Pearson’s r=0.05–0.39, Supplementary Table 4).  
 
Figure 1 presents the incidence rate ratios (IRR) from multilevel negative binomial 
regression models for the association between depressive symptoms and frequency of contact 
with an MD during the past 12 months. When adjusting for age, sex, country of interview and 
follow-up time, prior fatigue (IRR=1.15) and sleep problems (IRR=1.13) were most strongly 
associated with more frequent contact with an MD. Also, prior sad/depressed mood, 
tearfulness, concentration problems, guilt, irritability, changes in appetite and suicidal 
ideation were associated with higher frequency of contact with an MD (IRR=1.02-1.06) 
(Figure 1). These associations except for suicidal ideation (p=0.544) remained after 
additional adjustment for educational attainment, presence of a partner in household, BMI, 
the number of chronic diseases and disability (Figure 1, Supplementary Table 5). In the 
fully adjusted model, lack of enjoyment was associated with less frequent contact with an 
MD (IRR=0.98).  
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[ Figure 1 ] 
 
In multilevel logistic regression analyses adjusted for age, sex, country of interview and 
follow-up time, treatment for depression was most strongly associated with prior 
sad/depressed mood (OR=2.22) and suicidal ideation (OR=1.83) (Figure 2). Treatment for 
depression was also associated with prior sleep problems, changes in appetite, fatigue, 
concentration problems, hopelessness and irritability (OR=1.20-1.57) (Figure 2). Additional 
adjustment for educational attainment, presence of a partner in household, BMI, the number 
of chronic diseases, disability and frequency of contact with an MD at the follow-up baseline 
did not attenuate any of these associations (Figure 2, Supplementary Table 6).  
 
[ Figure 2 ] 
 
In analyses on inpatient psychiatric admission, the estimates were less precise due to the 
small number of cases admitted to inpatient treatment. Prior sad/depressed mood was most 
strongly associated with psychiatric inpatient admission (OR=2.77) (Figure 3). In addition, 
prior appetite change, fatigue, suicidal ideation, lack of enjoyment and sleep problems were 
more common among those admitted to inpatient psychiatric care (OR=1.52-1.77) (Figure 
3). After additional adjustment for educational attainment, presence of a partner in household, 
BMI, the number of chronic diseases, disability and frequency of contact with an MD at the 
follow-up baseline, most associations remained. However, the associations of suicidal 
ideation and lack of enjoyment with inpatient admission were no longer statistically 
significant (p=0.096 and p=0.066) (Figure 3, Supplementary Table 7). 
 
[ Figure 3 ] 
 
DISCUSSION 
In this longitudinal study among 53,139 aging people across Europe, depressive symptoms 
were differently related to health care utilization. People with more frequent contact with an 
MD had most often reported sleep problems and fatigue, followed by sad/depressed mood, 
tearfulness, concentration problems, guilt, irritability and changes in appetite in the previous 
study wave. By contrast, those treated for depression had most often reported sad/depressed 
mood and suicidal ideation, but also sleep problems, changes in appetite, fatigue, 
concentration problems, hopelessness and irritability. Sad/depressed mood was also 
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associated with subsequent admission to psychiatric inpatient care. Similarly to the other 
health care outcomes, appetite change, fatigue and sleep problems were more common 
among those admitted to psychiatric inpatient care.  
 
Previous studies among younger people with clinical depression have reported inconclusive 
findings.9–13 Most often, treatment utilization has been linked to suicidal ideation or 
behavior,10,12 sleep problems,9,10,12 fatigue,9,12,13 and difficulty to concentrate.10,12,13 We found 
evidence to support these associations, but also provide a more detailed picture of the 
symptom-specific associations in population-based data from SHARE.  
 
In our study, most depressive symptoms included in the EURO-D were associated both with 
visiting an MD and being treated for depression, suggesting they independently contribute to 
health care utilization. Although the same symptoms were associated with both these 
outcomes, there were differences in the relative magnitude of the associations. Two somatic 
symptoms – fatigue and sleep problems – were most strongly associated with higher 
frequency of contact with an MD. Previous literature has linked somatic depressive 
symptoms – sleep problems, fatigue, appetite change and psychomotor retardation or 
agitation – to poor physical health,14,15 and this association of somatic symptoms with greater 
health concern may be reflected as a higher frequency of contact with an MD, especially in 
older populations.2 Depressive symptoms, especially somatic symptoms, may also be 
characteristic physical conditions other than depression. Although we expected the 
associations between depressive symptoms and contact with an MD to attenuate after 
adjusting for chronic diseases and BMI, the associations were robust against confounding by 
these factors, suggesting the depressive symptoms contribute to health care utilization 
regardless of comorbid physical conditions. This is in line with previous studies suggesting 
that the age-associated declines in physical health do not explain all the increase in 
depressive symptoms among elderly people.1,27,28  
 
By contrast, two cognitive/affective symptoms of depression, sad/depressed mood and 
suicidal ideation were most strongly associated with higher likelihood of being treated for 
depression. Explanations for these associations likely involve the central role of these two 
symptoms in depression treatment context. Sad/depressed mood is a key symptom of 
depression which, together with anhedonia, is a core criterion for a depression diagnosis in 
the current diagnostic systems (both ICD and DSM-V),29,30 and it has been shown to play a 
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major role in diagnostic clinical decision-making.31 Suicidal ideation in turn, is an acute 
depressive symptom that clinicians tend to use when assessing depression severity.32 Suicidal 
ideation often requires immediate clinical attention and thus likely influences decisions over 
treatment and its course.33,34 
 
Sad/depressed mood was also associated with psychiatric inpatient treatment, together with 
somatic symptoms of fatigue, sleep problems and changes in appetite. However, these results 
were statistically imprecise and need to be interpreted with caution due to the low number of 
cases receiving psychiatric inpatient care in our analytic sample. Psychiatric inpatient 
treatment in the general population is rare,35 and often involves prior treatment contact.36,37 
Inpatient admission may result from a qualitative clinical assessment based on factors such as 
symptom severity or level of functional impairment rather than the presence of specific 
symptoms,36,37 and thus our data were not ideal for a detailed assessment of the determinants 
of hospitalization. Nevertheless, our results point to the relevance of sad/depressed mood to 
both outpatient and inpatient psychiatric treatment for depression, together with the cluster of 
somatic symptoms. 
 
We found no consistent evidence for associations of diminished interest and lack of 
enjoyment with health care utilization, although anhedonia in particular is often considered to 
be crucial in clinical depression.29,30 Depressive symptoms are associated with each other but 
the causal dynamics underlying these associations are not well understood. As we had no 
hypothesis about the underlying causal structure, we adjusted for all depressive symptoms in 
all models. The null findings may therefore reflect either a lack of true association due to 
proper control for confounding or overadjustment,38 the latter being a risk especially given 
that the associations between different depressive symptoms are likely bidirectional. 
However, it is also possible that interest loss and lack of enjoyment have naturally 
inconsistent associations with help-seeking behaviors. Although these symptoms have been 
associated with disability,39,40 thus providing incentive to seek treatment, motivational 
problems, feelings of detachment or apathy likely contained in these symptoms could 
counteract such incentive. The relevance of symptom-specific impairment to health care 
utilization, as well as the underlying mechanisms explaining the symptom-specific 
associations need to be explored further. However, it bears emphasis that none of the 
symptoms were consistently associated with lower probability of seeking treatment.  
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Some limitations should be noted. The data were from a longitudinal cohort study where loss 
to follow-up is inevitable. People experiencing depressive symptoms at follow-up baseline 
were more often lost to follow-up (Supplementary Tables 1–2), and selective attrition could 
have biased the observed associations. Like any observational study, we cannot rule out the 
possibility of residual or unmeasured confounding and our design does not allow for causal 
inference. Apart from the potential risk of overadjustment, we controlled for a set of relevant 
confounders associated with the depressive symptoms and health care outcomes. Although 
EURO-D is a validated measure of depression in the European population25,26 and the EURO-
D items have strong conceptual validity, self-reported measures of depressive symptoms 
involve the risk of reporting bias, and dichotomous items did not allow analyses 
incorporating symptom severity. Moreover, single-item measures of depressive symptoms 
may not perfectly discriminate individual depressive symptoms. However, correlations 
between depressive symptoms were weak, suggesting that there was no substantial overlap 
between the symptoms. The questionnaire item assessing treatment for depression was 
limited to treatment provided by a doctor/psychiatrist and thus may not have captured 
treatment provided by other mental health professionals. Finally, the participants were a 
rather old population-based cohort residing in Europe, which limits the generalizability of our 
findings.  
 
In conclusion, we observed differential associations of depressive symptoms with health care 
utilization among older adults in Europe. Elderly patients at different levels of the health care 
system may experience different depressive symptoms. The symptom-level approach can 
elucidate how readily a patient with a specific symptom profile will enter the health care 
system and what symptom combinations mostly occur at different levels of health care. Such 
symptom-level differences can contribute to understanding about inequalities of health care 
utilization and inform clinicians identifying and targeting elderly patients with depression. 
An important task for further research is to replicate these findings in other populations, 
elucidate the underlying mechanisms and evaluate the efficiency of received treatment among 
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Table 1.  The number of SHARE participants contributing data on depressive symptoms and treatment outcomes in each follow-up cycle 
      
      
  Follow-up from wave 1 to 2   Follow-up from wave 2 to 4   Follow-up from wave 4 to 5 
      
Wave1 Depressive symptoms n=22778     
      
      
      
Wave 2 Contact with an MD n=21532  Depressive symptoms n=22313   
 Depression treatment n=21240     
 Inpatient admission n=21240     
      
Wave 4   Contact with an MD n=20810  Depressive symptoms n=38441 
   Depression treatment n=18014   
   Inpatient admission n=18013   
      
Wave 5     Contact with an MD n=36819 
      
            








Figure 1. Adjusted incidence rate ratios for the associations of depressive symptoms with 
frequency of contact with a medical doctor during the past 12 months among SHARE participants 
 
Abbreviations: IRR, incidence rate ratio; CI, confidence interval 
All estimates are from multilevel negative binomial regression models with random intercepts.  
N=79,161 person-observations from 52,904 persons across 3 study waves. 
Minimally adjusted model adjusted for sex, age, country of interview, follow-up time and all other 
depressive symptoms. Fully adjusted model adjusted for sex, age, country of interview, follow-up 
time, educational attainment, presence of a partner in household, BMI, the number of chronic 
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Figure 2. Adjusted odds ratios for the associations of prior depressive symptoms with ever being 
treated for depression by a doctor or psychiatrist among SHARE participants 
 
Abbreviations: OR, odds ratio; CI, confidence interval 
All estimates are from multilevel logistic regression models with random intercepts. 
N=34,381 person-observations from 25,937 persons across 2 study waves.  
Minimally adjusted model adjusted for sex, age, country of interview, follow-up time and all other 
depressive symptoms. Fully adjusted model adjusted for sex, age, country of interview, follow-up 
time, educational attainment, presence of a partner in household, BMI, the number of chronic 
diseases, disability and frequency of contact with an MD at follow-up baseline. Plotted estimates 
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Figure 3. Adjusted odds ratios for the association of prior depressive symptoms with ever  
being admitted to a psychiatric hospital/ward among SHARE participants 
 
Abbreviations: OR, odds ratio; CI, confidence interval 
All estimates are from multilevel logistic regression models with random intercepts. 
N=38,539 person-observations from 28,254 persons across 2 study waves.  
Minimally adjusted model adjusted for sex, age, country of interview, follow-up time and all other 
depressive symptoms. Fully adjusted model adjusted for sex, age, country of interview, follow-up 
time, educational attainment, presence of a partner in household, BMI, the number of chronic 
diseases, disability and frequency of contact with an MD at follow-up baseline. Plotted estimates 
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Supplementary Table 1. Adjusted odds ratios for the associations of EURO-D sum score and 
covariates at each follow-up baseline with attrition at the end of the follow-up 
 
Supplementary Table 2. Adjusted odds ratios for the associations of depressive symptoms and 
covariates at each follow-up baseline with attrition at the end of the follow-up 
 
Supplementary Table 3. Characteristics of 53,139 participants from the Survey of Health, Aging 
and Retirement in Europe 
 
Supplementary Table 4. Correlations between depressive symptoms among SHARE participants 
 
Supplementary Table 5. Adjusted incidence rate ratios for the associations of depressive 
symptoms and covariates with frequency of contact with a medical doctor during the past 12 
months among SHARE participants 
 
Supplementary Table 6. Adjusted odds ratios for the associations of prior depressive symptoms 
and covariates with ever being treated for depression by a doctor or psychiatrist among SHARE 
participants 
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Supplementary Table 5. Adjusted incidence rate ratios for the associations of depressive 
symptoms and covariates with frequency of contact with a medical doctor during the past 12 
months among SHARE participants 
 
Supplementary Table 6. Adjusted odds ratios for the associations of prior depressive symptoms 
and covariates with ever being treated for depression by a doctor or psychiatrist among SHARE 
participants 
 
Supplementary Table 7. Adjusted odds ratios for the association of prior depressive symptoms 
and covariates with ever being admitted to a psychiatric hospital/ward among SHARE participants 
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Supplementary Table 1. Adjusted odds ratios for the associations of EURO-D sum 
score and covariates at each follow-up baseline with attrition at the end of the follow-up 
      
               OR   2.50% 97.50%    p-value 
Sex (female) 0.51 0.46 0.58 0.000 
Age 1.14 1.13 1.16 0.000 
Country     
 Austria 1.00 . . . 
 Germany 0.63 0.45 0.88 0.007 
 Sweden 1.65 1.24 2.19 0.001 
 Netherlands 1.19 0.88 1.59 0.257 
 Spain 2.23 1.70 2.93 0.000 
 Italy 0.68 0.51 0.90 0.008 
 France 0.72 0.55 0.95 0.019 
 Denmark 1.49 1.10 2.02 0.009 
 Greece 0.24 0.15 0.38 0.000 
 Switzerland 0.65 0.47 0.90 0.010 
 Belgium 0.60 0.46 0.79 0.000 
 Israel 10.29 7.40 14.32 0.000 
 Czech Republic 1.75 1.32 2.30 0.000 
 Poland 0.78 0.53 1.15 0.211 
 Slovenia 0.36 0.23 0.56 0.000 
 Estonia 1.03 0.78 1.35 0.854 
Follow-up time 1.41 1.36 1.46 0.000 
EURO-D sum score 1.26 1.23 1.29 0.000 
Abbreviations: OR, odds ratio     
All estimates are from mutually adjusted models.    
A total of 1507 (7%) participants were lost to follow-up between Waves 1–2, 2129 (9%) 




Supplementary Table 2. Adjusted odds ratios for the associations of depressive symptoms 
and covariates at each follow-up baseline with attrition at the end of the follow-up 
      
                     OR 2.50% 97.50% p-value 
Sex (female) 0.55 0.49 0.62 0.000 
Age 1.13 1.12 1.14 0.000 
Country     
 Austria 1.00 . . . 
 Germany 0.68 0.48 0.95 0.022 
 Sweden 1.70 1.28 2.26 0.000 
 Netherlands 1.23 0.92 1.64 0.169 
 Spain 2.07 1.59 2.70 0.000 
 Italy 0.69 0.52 0.92 0.012 
 France 0.77 0.59 1.01 0.058 
 Denmark 1.55 1.15 2.10 0.004 
 Greece 0.25 0.16 0.39 0.000 
 Switzerland 0.72 0.52 0.99 0.044 
 Belgium 0.63 0.48 0.82 0.001 
 Israel 10.36 7.61 14.11 0.000 
 Czech Republic 1.79 1.36 2.36 0.000 
 Poland 0.80 0.54 1.17 0.243 
 Slovenia 0.37 0.24 0.58 0.000 
 Estonia 1.14 0.87 1.50 0.340 
Follow-up time 1.41 1.36 1.46 0.000 
Sad/depressed mood 0.98 0.88 1.10 0.724 
Hopelessness 1.45 1.28 1.64 0.000 
Suicidal ideation 1.47 1.24 1.74 0.000 
Guilt 0.64 0.54 0.77 0.000 
Sleep problems 1.06 0.95 1.18 0.284 
Diminished interest 1.56 1.34 1.82 0.000 
Irritability 0.90 0.80 1.00 0.058 
Changes in appetite 2.13 1.83 2.47 0.000 
Fatigue 1.55 1.39 1.72 0.000 
Concentration problems 1.49 1.32 1.67 0.000 
Lack of enjoyment 1.46 1.29 1.67 0.000 
Tearfulness  1.07 0.95 1.21 0.256 
Abbreviations: OR, odds ratio     
All estimates are from mutually adjusted models.    
A total of 1507 (7%) participants were lost to follow-up between Waves 1–2, 2129 (9%) 
between Waves 2–4 and 2577 (7%) participants between Waves 4–5.  
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Supplementary Table 3. Characteristics of 53,139 participants from the Survey of Health, Aging and Retirement in Europe   
              
   Follow-up from wave 1 to 2  Follow-up from wave 2 to 4  Follow-up from wave 4 to 5  
      Mean (SD) n [%] N   Mean (SD) n [%] N   Mean (SD) n [%] N 
Age   63.7 (10.3)  22778  64.4 (9.9)  22313  65.6 (10.1)  38441 
Sex (women)   12722 [56%] 22778   12480 [56%] 22313   21943 [57%] 38441 
Country    22778    22313    38441 
 Austria   1255 [6%]    839 [4%]    3956 [10%]  
 Germany   1778 [8%]    1487 [7%]    1062 [3%]  
 Sweden   2386 [10%]    2000 [9%]    1455 [4%]  
 Netherlands   1998 [9%]    1746 [8%]    2174 [6%]  
 Spain   1768 [8%]    1775 [8%]    2902 [8%]  
 Italy   1929 [8%]    2272 [10%]    2622 [7%]  
 France   2286 [10%]    2067 [9%]    3884 [10%]  
 Denmark   1402 [6%]    2004 [9%]    1958 [5%]  
 Greece   2388 [10%]          
 Switzerland   730 [3%]    1080 [5%]    2933 [8%]  
 Belgium   2973 [13%]    2406 [11%]    3935 [10%]  
 Israel   1885 [8%]    1594 [7%]      
 Czech Republic       1433 [6%]    4045 [11%]  
 Poland       1610 [7%]      
 Slovenia           1947 [5%]  
 Estonia           5568 [14%]  
Follow-up time (years)  3.0 (1.5)  22778  4.4 (0.8)  22313  2.0 (0.2)  38441 
Educational attainment (ISCED-97)   22778    22313    38441 
 None   1248 [5%]    841 [4%]    1079 [3%]  
 1   6482 [28%]    5625 [25%]    6813 [18%]  
 2   3933 [17%]    3833 [17%]    7529 [20%]  
 3   6114 [27%]    6622 [30%]    12976 [34%]  
 4   606 [3%]    814 [4%]    1858 [5%]  
 5   4295 [19%]    4477 [20%]    7860 [20%]  
 6   100 [0.4%]    101 (0.5%]    326 [1%]  
Presence of a partner in household  16992 [75%] 22778   16958 [76%] 22313   27551 [72%] 38441 
 5 
Number of chronic diseases  0.7 (0.9)  22778  0.8 (0.9)  22313  0.9 (0.9)  38441 
Body mass index (kg/m2)  26.0 (5.5)  22778  26.1 (5.7)  22313  26.1 (6.6)  38441 
Disability   2099 [9%] 22778   2058 [9%] 22313   4149 [11%] 38441 
Depressive symptoms    22778    22313    38441 
 Sad/depressed mood   8757 [38%]    8410 [38%]    15702 [41%]  
 Hopelessness   3178 [14%]    3299 [15%]    6928 [18%]  
 Suicidal ideation   1597 [7%]    1454 [7%]    2860 [7%]  
 Guilt   1900 [8%]    1758 [8%]    3412 [9%]  
 Sleep problems   7102 [31%]    7457 [33%]    13585 [35%]  
 Diminished interest   2046 [9%]    1902 [9%]    3253 [8%]  
 Irritability   5595 [25%]    5748 [26%]    11215 [29%]  
 Changes in appetite   1841 [8%]     1807 [8%]    3196 [8%]  
 Fatigue   7301 [32%]    7435 [33%]    14133 [37%]  
 Concentration problems  4725 [21%]     4182 [19%]    6806 [18%]  
 Lack of enjoyment   3061  [13%]    2812 [13%]    4851 [13%]  
 Crying   6220 [27%]    5638 [25%]    9432 [25%]  
Frequency of contact with an MDa,b 6.4 (6.9)  21532  6.7 (6.8)  20810  6.5 (6.8)  36819 
Treated for depressionb,c   1446 [7%] 21240   1303 [7%] 18014     
Inpatient admissionc,d     137 [0.7%] 21240     173 [1%] 18013         
Across all follow-ups, N=79,467 person-observations from 53,139 persons across 3 study waves      
Not all percentages add up to 100% due to rounding.           
All values are calculated at the follow-up baseline unless otherwise noted.         
a During past 12 months             
b Ever treated for depression by a doctor/psychiatrist           
c At the end of each follow-up (i.e. in the later study wave)          
d Ever admitted to a psychiatric hospital/ward           





Supplementary Table 4. Correlations between depressive symptoms among SHARE participants    
             
  1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
1. Sad/depressed mood             
2. Hopelessness 0.13            
3. Suicidal ideation 0.25 0.19           
4. Guilt 0.20 0.06 0.18          
5. Sleep problems 0.30 0.11 0.17 0.13         
6. Diminished interest 0.18 0.17 0.22 0.12 0.17        
7. Irritability 0.30 0.08 0.16 0.15 0.21 0.14       
8. Changes in appetite 0.17 0.12 0.18 0.09 0.17 0.21 0.13      
9. Fatigue 0.31 0.13 0.20 0.14 0.25 0.20 0.24 0.20     
10. Concentration problems 0.15 0.13 0.16 0.09 0.15 0.21 0.12 0.15 0.20    
11. Lack of enjoyment 0.08 0.20 0.12 0.05 0.08 0.18 0.07 0.12 0.11 0.15   
12. Tearfulness  0.39 0.06 0.21 0.14 0.21 0.15 0.20 0.16 0.20 0.14 0.07   
All correlations are statistically significant (p<0.001).           
Depressive symptoms measured at the first wave available for each participant (n=53,139).     
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Supplementary Table 5. Adjusted incidence rate ratios for the associations of depressive 
symptoms and covariates with frequency of contact with a medical doctor during the past 
12 months among SHARE participants 
       
    IRR 2.50% 97.50% z-score p-value 
Sex (female) 1.09 1.08 1.11 12.05 0.000 
Age 1.01 1.01 1.01 30.10 0.000 
Country      
 Austria 1.00 . . . . 
 Germany 1.14 1.09 1.18 6.67 0.000 
 Sweden 0.54 0.52 0.56 -32.00 0.000 
 Netherlands 0.75 0.73 0.78 -15.25 0.000 
 Spain 0.99 0.95 1.02 -0.70 0.483 
 Italy 1.07 1.03 1.11 3.89 0.000 
 France 1.08 1.04 1.11 4.69 0.000 
 Denmark 0.73 0.70 0.76 -16.37 0.000 
 Greece 0.79 0.75 0.82 -10.34 0.000 
 Switzerland 0.77 0.75 0.80 -13.48 0.000 
 Belgium 1.19 1.15 1.22 10.96 0.000 
 Israel 1.04 0.99 1.08 1.69 0.092 
 Czech Republic 1.08 1.05 1.12 4.63 0.000 
 Poland 0.94 0.89 0.99 -2.50 0.012 
 Slovenia 0.75 0.72 0.79 -11.73 0.000 
 Estonia 0.69 0.67 0.72 -20.65 0.000 
Follow-up time 1.02 1.02 1.03 9.84 0.000 
Educational attainment 1.00 1.00 1.01 0.43 0.669 
Partner in household 1.03 1.01 1.05 3.58 0.000 
BMI 1.01 1.01 1.01 12.72 0.000 
Number of chronic diseases 1.24 1.24 1.25 60.03 0.000 
Disability 1.13 1.10 1.15 11.29 0.000 
Sad/depressed mood 1.06 1.04 1.07 7.90 0.000 
Hopelessness 0.99 0.97 1.01 -1.23 0.218 
Suicidal ideation 1.01 0.98 1.03 0.61 0.544 
Guilt 1.03 1.01 1.05 2.91 0.004 
Sleep problems 1.10 1.09 1.12 13.72 0.000 
Diminished interest 1.01 0.99 1.03 0.86 0.390 
Irritability 1.03 1.02 1.04 4.03 0.000 
Changes in appetite 1.03 1.01 1.05 2.57 0.010 
Fatigue 1.10 1.08 1.12 13.51 0.000 
Concentration problems 1.03 1.02 1.05 3.95 0.000 
Lack of enjoyment 0.98 0.96 1.00 -2.39 0.017 
Tearfulness  1.04 1.02 1.06 5.07 0.000 
 
N=79,161 person-observations from 52,904 persons across 3 study waves  
Abbreviations: IRR, incidence rate ratio; body mass index    
All estimates are from mutually adjusted models.     




Supplementary Table 6. Adjusted odds ratios for the associations of prior depressive 
symptoms and covariates with ever being treated for depression by a doctor or psychiatrist 
among SHARE participants 
       
    OR 2.50% 97.50% z-score p-value 
Sex (female) 1.98 1.61 2.43 6.44 0.000 
Age 0.98 0.97 0.99 -4.94 0.000 
Country      
 Austria 1 . . . . 
 Germany 0.88 0.57 1.38 -0.54 0.589 
 Sweden 0.87 0.55 1.35 -0.63 0.529 
 Netherlands 0.81 0.52 1.28 -0.90 0.366 
 Spain 2.05 1.32 3.19 3.19 0.001 
 Italy 0.88 0.57 1.35 -0.60 0.549 
 France 0.96 0.62 1.47 -0.21 0.835 
 Denmark 1.21 0.77 1.89 0.83 0.405 
 Greece 0.14 0.07 0.30 -5.23 0.000 
 Switzerland 0.78 0.46 1.32 -0.93 0.351 
 Belgium 1.34 0.89 2.03 1.40 0.161 
 Israel 1.30 0.82 2.06 1.10 0.270 
 Czech Republic 1.51 0.92 2.47 1.64 0.101 
 Poland 0.26 0.14 0.48 -4.28 0.000 
Follow-up time 1.27 1.16 1.38 5.29 0.000 
Educational attainment 0.98 0.92 1.04 -0.75 0.454 
Partner in household 0.92 0.77 1.11 -0.84 0.402 
BMI 0.99 0.98 1.01 -1.15 0.248 
Number of chronic diseases 1.09 1.00 1.20 1.87 0.061 
Disability 1.44 1.12 1.85 2.83 0.005 
Frequency of prior contact with an MD 1.03 1.02 1.04 4.50 0.000 
Sad/depressed mood 2.18 1.78 2.67 7.51 0.000 
Hopelessness 1.24 1.00 1.54 1.96 0.050 
Suicidal ideation 1.72 1.30 2.29 3.74 0.000 
Guilt 1.19 0.92 1.53 1.32 0.188 
Sleep problems 1.48 1.25 1.76 4.57 0.000 
Diminished interest 0.99 0.76 1.28 -0.11 0.910 
Irritability 1.20 1.00 1.43 2.00 0.045 
Changes in appetite 1.40 1.08 1.82 2.54 0.011 
Fatigue 1.35 1.14 1.61 3.47 0.001 
Concentration problems 1.24 1.03 1.50 2.25 0.024 
Lack of enjoyment 1.07 0.86 1.34 0.63 0.526 
Tearfulness  1.13 0.94 1.35 1.33 0.184 
 
N=34,381 person-observations from 25,937 persons across 2 study waves  
Abbreviations: OR, odds ratio; BMI, body mass index; MD, medical doctor  
All estimates are from mutually adjusted models.     




Supplementary Table 7. Adjusted odds ratios for the association of prior depressive 
symptoms and covariates with ever being admitted to a psychiatric hospital/ward among 
SHARE participants        
    OR 2.50% 97.50% z-score p-value 
Sex (female) 0.86 0.58 1.26 -0.79 0.431 
Age 0.96 0.93 0.98 -3.84 0.000 
Country      
 Austria 1 . . . . 
 Germany 1.99 0.63 6.31 1.17 0.244 
 Sweden 1.24 0.38 4.12 0.36 0.720 
 Netherlands 0.86 0.24 3.01 -0.24 0.810 
 Spain 1.44 0.46 4.56 0.63 0.531 
 Italy and Greece 0.75 0.24 2.39 -0.48 0.629 
 France 1.58 0.52 4.83 0.81 0.420 
 Denmark 1.31 0.39 4.43 0.43 0.667 
 Switzerland 1.74 0.48 6.27 0.85 0.395 
 Belgium 2.31 0.76 6.97 1.48 0.138 
 Israel 0.92 0.24 3.44 -0.13 0.898 
 Czech Republic 5.75 1.71 19.26 2.83 0.005 
 Poland 0.66 0.18 2.45 -0.62 0.536 
Follow-up time 1.44 1.20 1.72 3.93 0.000 
Educational attainment 0.88 0.76 1.02 -1.71 0.088 
Partner in household 0.65 0.43 0.99 -2.01 0.044 
BMI 0.98 0.96 1.01 -1.17 0.244 
Number of chronic diseases 1.01 0.82 1.26 0.13 0.897 
Disability 0.90 0.51 1.59 -0.36 0.717 
Frequency of contact with an MD 1.03 1.00 1.05 1.94 0.053 
Sad/depressed mood 2.87 1.76 4.70 4.20 0.000 
Hopelessness 0.95 0.59 1.55 -0.19 0.851 
Suicidal ideation 1.59 0.92 2.74 1.66 0.096 
Guilt 1.01 0.59 1.75 0.05 0.958 
Sleep problems 1.53 1.03 2.27 2.10 0.036 
Diminished interest 1.29 0.76 2.18 0.94 0.347 
Irritability 0.92 0.62 1.37 -0.41 0.684 
Changes in appetite 1.74 1.03 2.96 2.05 0.040 
Fatigue 1.61 1.07 2.43 2.26 0.024 
Concentration problems 1.16 0.76 1.76 0.70 0.485 
Lack of enjoyment 1.57 0.97 2.54 1.84 0.066 
Tearfulness  0.66 0.43 1.01 -1.90 0.057 
 
N=38,539 person-observations from 28,254 persons across 2 study waves  
Abbreviations: OR, odds ratio; BMI, body mass index; MD, medical doctor  
All estimates are from mutually adjusted models.     
All covariates measured at each follow-up baseline.     
 
